{"schema_version":"secwatch.filing_event.v1","accession":"0000882835-22-000005","form_type":"8-K","ticker":"ROP","cik":"0000882835","company_name":"ROPER TECHNOLOGIES INC","filed_at":"2022-02-02T23:59:59+00:00","discovered_at":"2026-05-14T18:04:10.147282+00:00","generated_at":"2026-06-27T12:41:08.897629+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Roper Q4 rev +13% to $1.51B; adj EPS $3.73; guides FY22 adj DEPS $15.25-$15.55","bullets":["Q4 GAAP revenue $1.51B (+13% organic); GAAP DEPS $1.87, adjusted DEPS $3.73.","FY21 revenue $5.78B (+19%); adjusted EBITDA $2.21B (+22%); free cash flow $1.80B (+19%).","FY22 adjusted DEPS guidance $15.25-$15.55; Q1 adj DEPS $3.63-$3.67.","TransCore divestiture expected to close Q1 2022; Zetec and CIVCO Radiotherapy completed.","CEO cites software recurring revenue momentum and record backlog as tailwinds."],"urls":{"canonical":"https://secwatch.observer/filing/0000882835-22-000005","json":"https://secwatch.observer/filing/0000882835-22-000005.json","markdown":"https://secwatch.observer/filing/0000882835-22-000005.md","text":"https://secwatch.observer/filing/0000882835-22-000005.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/882835/000088283522000005/0000882835-22-000005-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/882835/000088283522000005/rop-20220202.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T12:41:08.897629+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}